| Dear Fellow Trader, |
| I hope this trading day has been good to you! I am sending you trade ideas for tomorrow. So you can have enough time to take action on our trades ideas. |
NNVC: This Tiny Biotech Could Break Out in 2026 (ad)*
NanoViricides (NYSE: NNVC) is approaching a pivotal moment as its lead antiviral, NV-387, advances toward Phase II. Unlike traditional antivirals, NV-387 uses a nanoviricide platform designed to directly attack viruses while shielding organs from immune-related damage. It has shown remarkable survival benefits in humanized animal models and demonstrated strong safety in Phase I trials. With measles outbreaks rising and global viral threats expanding, NV-387's broad-spectrum potential—from influenza and RSV to MPox and smallpox—positions NNVC for major commercial traction. Two Phase II tracks, including an MPox trial in Congo and a multi-virus trial in India, set up a significant 2026 catalyst.
👉 Discover why NV-387 could become one of 2026's most important antiviral breakthroughs. |
| Options Trade Ideas (Volatility Rush Strategy) |
| The basic option trade idea is to buy an at-the-money straddle while the options premium is cheap. |
| In assessing this trade, you need to do your homework to ensure you are not paying too much for the straddle. |
| As the earnings date approaches, the implied volatility (IV) should increase, resulting in greater price movement. |
| However, be aware that you should close your position before the announcement comes out in order to maximize your profit potential. That's because once earnings are released, IV will fall dramatically, which will greatly reduce your opportunity to profit on the trade. |
| The stocks (with Weekly Options) below are announcing earnings in next few weeks. Our proprietary volatility algorithm suggests these stocks are likely to experience high volatility as earnings day approaches. |
| |
|
 | Before Market Open |  | After Market Close | |
| *Predicted Volatility % based on our Proprietary Volatility Predication Model. We are expecting that stock price will likely to reach % in either direction by the end of next trading session after Earnings are released and not necessarily the closing volatility %. |
،🚀 #1 coin set to soar 25X – starting November 18 🗓️ (ad)
This tiny 3-cent crypto just partnered with 19 of the biggest companies in the world… from the largest world superpowers (US & China). And one team of crypto experts has identified it as the most promising crypto of 2025.
✅️ Claim the ticker here >>> |
NNVC: The Under-the-Radar Biotech That Could Redefine Antiviral Therapy in 2026 (ad)*
NanoViricides (NYSE: NNVC) is advancing NV-387, a broad-spectrum antiviral that neutralizes viruses before they infect cells while protecting the lungs from immune-driven damage. With U.S. measles cases rising, NV-387 has shown 130% increased survival and strong lung protection in humanized models. Phase I trials confirmed safety, and its oral gummy formulation makes it patient-friendly during severe illness. NV-387's nanoviricide "Re-Infection Inhibition" technology targets measles, RSV, influenza, COVID-19, MPox, H5N1, and even smallpox—unlocking multi-billion-dollar global markets. Two Phase II tracks—a Congo MPox study and a multi-virus basket trial in India—position NNVC for major catalysts in 2026.
👉 Learn why NV-387 could be one of 2026's biggest antiviral breakthroughs. |
| At StockEarnings, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. |
| To your trading success, |
| Hiral Ghelani |
| Founder & CEO |
| StockEarnings, Inc |
| 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA |
| W: 877.6.STOCKS (Mon to Sat | 9am to 5pm EST | Feel Free to Call Us) |
| |
|
(ad)* This message is a PAID ADVERTISEMENT for NanoViricides, Inc (NYSE: NNVC) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $7000.00 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Nov 14, 2025 and Nov 20, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either NanoViricides, Inc (NYSE: NNVC) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding NanoViricides, Inc (NYSE: NNVC) on Smallcaps Daily website for additional information about the relationship between Interactive Offers and NanoViricides, Inc (NYSE: NNVC). StockEarnings, Inc (SE) is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS |
Unsubscribe
Today's Bonus Content: Millionaires will be made
|
